Cetero has filed for bankruptcy protection and through the Chapter 11 process will seek to maximize the recovery of assets for its creditors. The company has secured a Debtor-in-Possession (DIP) financing of $15 million to provide working capital during the restructuring process. Cetero, based in Cary, NC, provides early-phase clinical research and bioanalytics services for pharmaceutical companies to support drug applications. In July 2011, the FDA reported that two inspections, as well as an ...